These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 27069077)

  • 1. Reply to N.F. Saba and S.J. Wong.
    Harrington KJ; Bourhis J
    J Clin Oncol; 2016 Jun; 34(17):2073-4. PubMed ID: 27069077
    [No Abstract]   [Full Text] [Related]  

  • 2. Erratum.
    Science; 1987 Feb; 235(4789):623f. PubMed ID: 17833610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple rule to identify patients with chronic obstructive pulmonary disease who may need treatment reevaluation.
    Sharafkhaneh A; Altan AE; Colice GL; Hanania NA; Donohue JF; Kurlander JL; Rodriguez-Roisin R; Altman PR
    Respir Med; 2014 Sep; 108(9):1310-20. PubMed ID: 25130680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SabA is the H. pylori hemagglutinin and is polymorphic in binding to sialylated glycans.
    Aspholm M; Olfat FO; Nordén J; Sondén B; Lundberg C; Sjöström R; Altraja S; Odenbreit S; Haas R; Wadström T; Engstrand L; Semino-Mora C; Liu H; Dubois A; Teneberg S; Arnqvist A; Borén T
    PLoS Pathog; 2006 Oct; 2(10):e110. PubMed ID: 17121461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic diversity of the Helicobacter pylori sialic acid-binding adhesin (sabA) gene.
    Shao L; Takeda H; Fukui T; Mabe K; Han J; Kawata S; Ootani K; Fukao A
    Biosci Trends; 2010 Oct; 4(5):249-53. PubMed ID: 21068478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanical binding strengths of Helicobacter pylori BabA and SabA adhesins using an adhesion binding assay-ELISA, and its clinical relevance in Japan.
    Nishioka M; Takeuchi H; Con SA; Uehara Y; Nishimori I; Okumiya T; Kumon Y; Sugiura T
    Microbiol Immunol; 2010 Aug; 54(8):442-51. PubMed ID: 20646208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with inhaled mometasone furoate reduces short-acting β(2) agonist claims and increases adherence compared to fluticasone propionate in asthma patients.
    Navaratnam P; Friedman HS; Urdaneta E
    Value Health; 2011; 14(2):339-46. PubMed ID: 21402302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-time asthma outreach reduces excessive short-acting β2-agonist use: a randomized study.
    Zeiger RS; Schatz M; Li Q; Solari PG; Zazzali JL; Chen W
    J Allergy Clin Immunol Pract; 2014; 2(4):445-456, 456.e1-5. PubMed ID: 25017534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obtaining optimal control in mild asthma: theory and practice.
    Watson L; Kerstjens HA; Rabe KF; Kiri V; Visick GT; Postma DS
    Fam Pract; 2005 Jun; 22(3):305-10. PubMed ID: 15805133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intervention to reduce unnecessary dispensing of short-acting {beta}-agonists in patients with asthma.
    Wong MD; Manley RT; Stettin G; Chen W; Salmun LM
    Ann Pharmacother; 2010 Apr; 44(4):623-9. PubMed ID: 20233916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Length of thymidine homopolymeric repeats modulates promoter activity of sabA in Helicobacter pylori.
    Kao CY; Sheu SM; Sheu BS; Wu JJ
    Helicobacter; 2012 Jun; 17(3):203-9. PubMed ID: 22515358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-acting β-agonist use and its ability to predict future asthma-related outcomes.
    Stanford RH; Shah MB; D'Souza AO; Dhamane AD; Schatz M
    Ann Allergy Asthma Immunol; 2012 Dec; 109(6):403-7. PubMed ID: 23176877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection of sabA-positive H. pylori does not induce anti-Lewis X antibody in host.
    Nakasato F; Shimoyama T; Yoshimura T; Mikami T; Munakata A; Fukuda S
    Hepatogastroenterology; 2008; 55(84):1122-5. PubMed ID: 18705343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Population Health Management Using the Propeller Health Asthma Platform: A Randomized Clinical Trial.
    Merchant RK; Inamdar R; Quade RC
    J Allergy Clin Immunol Pract; 2016; 4(3):455-63. PubMed ID: 26778246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between host gastric Sialyl-Lewis X and H. pylori SabA enhances H. pylori density in patients lacking gastric Lewis B antigen.
    Sheu BS; Odenbreit S; Hung KH; Liu CP; Sheu SM; Yang HB; Wu JJ
    Am J Gastroenterol; 2006 Jan; 101(1):36-44. PubMed ID: 16405531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-acting beta-agonist prescription fills as a marker for asthma morbidity.
    Naureckas ET; Dukic V; Bao X; Rathouz P
    Chest; 2005 Aug; 128(2):602-8. PubMed ID: 16100144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled corticosteroids are more effective in COPD patients when used with LABA than with SABA.
    Kiri VA; Bettoncelli G; Testi R; Viegi G
    Respir Med; 2005 Sep; 99(9):1115-24. PubMed ID: 15921904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of asthma medication use: early asthma therapy initiation and asthma outcomes at age 8.
    Koster ES; Wijga AH; Zuidgeest MG; Belitser SV; Raaijmakers JA; Koppelman GH; Postma DS; Brunekreef B; de Jongste JC; Maitland-van der Zee AH
    Pharmacoepidemiol Drug Saf; 2010 Oct; 19(10):991-9. PubMed ID: 20712022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of bronchodilators on regional lung sound distribution in patients with chronic obstructive pulmonary disease.
    Mineshita M; Matsuoka S; Miyazawa T
    Respiration; 2014; 87(1):45-53. PubMed ID: 23860295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of all-cause hospitalization in COPD patients initiating long-acting or short-acting beta agonist therapy.
    Bollu V; Ejzykowicz F; Rajagopalan K; Karafilidis J; Hay JW
    J Med Econ; 2013 Aug; 16(8):1082-8. PubMed ID: 23777224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.